106 related articles for article (PubMed ID: 8822588)
21. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
[TBL] [Abstract][Full Text] [Related]
22. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.
Muñoz-Cánoves P; Miralles F; Baiget M; Félez J
Thromb Haemost; 1997 Mar; 77(3):526-34. PubMed ID: 9066006
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines.
Shiratsuchi T; Ishibashi H; Shirasuna K
J Cell Physiol; 2002 Dec; 193(3):340-8. PubMed ID: 12384986
[TBL] [Abstract][Full Text] [Related]
25. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.
Cheng T; Cao W; Wen R; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870
[TBL] [Abstract][Full Text] [Related]
27. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
Pakneshan P; Szyf M; Rabbani SA
Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
[TBL] [Abstract][Full Text] [Related]
28. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
[TBL] [Abstract][Full Text] [Related]
29. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.
Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ
Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells.
Tatsuda Y; Iguchi K; Usui S; Suzui M; Hirano K
Eur J Pharmacol; 2010 Feb; 627(1-3):348-53. PubMed ID: 19903468
[TBL] [Abstract][Full Text] [Related]
32. C-phycocyanin transcriptionally regulates uPA mRNA through cAMP mediated PKA pathway in human fibroblast WI-38 cells.
Madhyastha HK; Radha KS; Sugiki M; Omura S; Maruyama M
Biochim Biophys Acta; 2006 Nov; 1760(11):1624-30. PubMed ID: 17029796
[TBL] [Abstract][Full Text] [Related]
33. Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells.
Kiguchi T; Niiya K; Shibakura M; Miyazono T; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Nakata Y; Harada M
Int J Cancer; 2001 Sep; 93(6):792-7. PubMed ID: 11519039
[TBL] [Abstract][Full Text] [Related]
34. Camptothecin induces urokinase-type plasminogen activator gene-expression in human RC-K8 malignant lymphoma and H69 small cell lung cancer cells.
Shibakura M; Niiya K; Kiguchi T; Nakata Y; Tanimoto M
Acta Med Okayama; 2002 Oct; 56(5):223-7. PubMed ID: 12530505
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin I2 analog enhances the expression of urokinase-type plasminogen activator and wound healing in cultured human fibroblast.
Hatane T; Yoshida E; Kawano J; Sugiki M; Onitsuka T; Maruyama M
Biochim Biophys Acta; 1998 Jun; 1403(2):189-98. PubMed ID: 9630624
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
Ziegler A; Knesel J; Fabbro D; Nagamine Y
J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
[TBL] [Abstract][Full Text] [Related]
37. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level.
Kainoh M; Maruyama I; Nishio S; Nakadate T
Biochem Pharmacol; 1991 Apr; 41(8):1135-40. PubMed ID: 1706920
[TBL] [Abstract][Full Text] [Related]
38. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
Kobayashi H; Gotoh J; Terao T
Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
[TBL] [Abstract][Full Text] [Related]
39. A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury.
Yano T; Itoh Y; Kubota T; Sendo T; Oishi R
Kidney Int; 2004 May; 65(5):1654-63. PubMed ID: 15086904
[TBL] [Abstract][Full Text] [Related]
40. Orally active prostacyclin analogue for cardiovascular disease.
Nagaya N
Int Angiol; 2010 Apr; 29(2 Suppl):14-8. PubMed ID: 20357744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]